William Waterfield

1.4k citations
13 papers · 1.1k · 1 hit paper · h-index 7

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
    • Cutaneous Melanoma Detection and Management
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • CAR-T cell therapy research 3
    • Cancer Immunotherapy and Biomarkers 3
    • Cancer Treatment and Pharmacology 2
    • Peptidase Inhibition and Analysis 1

William Waterfield

13 papers receiving 1.1k citations

William Waterfield's Hit Papers

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study 2009 · 934 citations
9340+5+11Years since publication250500750

Peers

William Waterfield
Comparison fields: 5 of 74
  • Oncology 997
  • Immunology 497
  • Anesthesiology and Pain Medicine 37
  • Cancer Research 76
  • Pulmonary and Respiratory Medicine 153
Replace V. Guillem Porta with:
V. Guillem Porta Spain
Tomasz Sarosiek Poland
Chara Stavraka United Kingdom
Dominique Cazals France
Julio Astudillo Spain
Marco Siano Switzerland
Pamela Lockbaum United States
T. Megha Italy
E. Corgna Italy
William Waterfield relative to V. Guillem Porta Spain V. Guillem Porta's profile →
Citations per field
00.5×5.5×
V. Guillem Porta · 1×
Citations per year

Countries citing papers authored by William Waterfield

Since Specialization
Citations

This map shows the geographic impact of William Waterfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Waterfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Waterfield more than expected).

Fields of papers citing papers by William Waterfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Waterfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Waterfield. The network helps show where William Waterfield may publish in the future.

Co-authors

The 25 scholars most cited alongside William Waterfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Waterfield Line = papers co-authored together William Waterfield links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Hit paper breakdown →
2009934
2 201165
3 200147
4 199033
5
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
198523
6 197815
7 199613
8 20094
9 19993
10
Results of curative therapy for esophageal cancer in a community training hospital.
20033
11
The lay of Alha : a saga of Rajput chivalry as sung by minstrels of northern India
19902
12
Neutropenia and fever in patients receiving chemotherapy in a community teaching hospital: results of a retrospective chart review.
19942
13
Benchmarking as a means of improving the financial wellbeing of organic dairy farms
20022

About William Waterfield

William Waterfield is a scholar working on Oncology, Surgery, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Genomics and Diagnostics (2 papers), Peptidase Inhibition and Analysis (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (997 citations), Immunology (497 citations), Anesthesiology and Pain Medicine (37 citations), Cancer Research (76 citations) and Pulmonary and Respiratory Medicine (153 citations). William Waterfield has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Jedd D. Wolchok, Troy H. Guthrie, Célèste Lebbé, Bart Neyns, Jose Lutzky, Michael Smylie, Kun Chen, Steven O’Day, L. Thomas and Sylvie Négrier. Their work appears in journals such as Cancer, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, American Journal of Dermatopathology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact